Tim Evans
Stock Analyst at Wells Fargo
(1.72)
# 2,131
Out of 4,433 analysts
19
Total ratings
78.57%
Success rate
10.74%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTLT Catalent | Maintains: Equal-Weight | $50 → $42 | $55.37 | -24.15% | 3 | Nov 16, 2023 | |
| MEDP Medpace Holdings | Maintains: Market Perform | n/a | $393.30 | - | 2 | Feb 28, 2018 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | n/a | $293.85 | - | 2 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $111.07 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | n/a | $355.64 | - | 1 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | n/a | $144.34 | - | 2 | Oct 20, 2017 | |
| LH Laboratory Corporation of America Holdings | Reinstates: Outperform | n/a | $213.13 | - | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $83.81 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | n/a | $265.80 | - | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,522.75 | - | 1 | Jul 13, 2017 | |
| BRKR Bruker | Downgrades: Underperform | n/a | $75.07 | - | 1 | Jul 13, 2017 | |
| A Agilent Technologies | Upgrades: Outperform | n/a | $154.23 | - | 1 | Jul 13, 2017 | |
| INCR InterCure | Downgrades: Market Perform | n/a | $3.29 | - | 1 | May 3, 2017 |
Catalent
Nov 16, 2023
Maintains: Equal-Weight
Price Target: $50 → $42
Current: $55.37
Upside: -24.15%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: n/a
Current: $393.30
Upside: -
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: n/a
Current: $293.85
Upside: -
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $111.07
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: n/a
Current: $355.64
Upside: -
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: n/a
Current: $144.34
Upside: -
Laboratory Corporation of America Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: n/a
Current: $213.13
Upside: -
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $83.81
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $265.80
Upside: -
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,522.75
Upside: -
Bruker
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $75.07
Upside: -
Agilent Technologies
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $154.23
Upside: -
InterCure
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $3.29
Upside: -